A detailed history of Amalgamated Bank transactions in X Biotech Inc. stock. As of the latest transaction made, Amalgamated Bank holds 640 shares of XBIT stock, worth $2,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
640
Previous 640 -0.0%
Holding current value
$2,489
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.54 - $9.89 $2,905 - $6,329
640 New
640 $3,000
Q2 2022

Aug 15, 2022

SELL
$5.13 - $9.2 $9,449 - $16,946
-1,842 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$8.64 - $11.71 $15,914 - $21,569
1,842 New
1,842 $16,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $118M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.